Evidence map›Paper›PMID 26855562›Full record

ArticleDrug design, development and therapy2016

The improvement effects of edible bird's nest on proliferation and activation of B lymphocyte and its antagonistic effects on immunosuppression induced by cyclophosphamide.

Ran Zhao, Geng Li, Xiu-Juan Kong, Xiu-Yan Huang, Wei Li, Yao-Ying Zeng, Xiao-Ping Lai

Open access · goldAbstract read
In one paragraph

Article in Drug design, development and therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Restorative Effects of Inulin FromFrontiers in pharmacology · 2022
    Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ran ZhaoTraditional Chinese Medicinal College, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
Geng LiTraditional Chinese Medicinal College, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
Xiu-Juan KongTraditional Chinese Medicinal College, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
Xiu-Yan HuangLife Science College, Jinan University, Guangzhou, People's Republic of China.
Wei LiTraditional Chinese Medicinal College, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China.
Yao-Ying ZengLife Science College, Jinan University, Guangzhou, People's Republic of China.
Xiao-Ping LaiDongguan Mathematical Engineering Academy of Chinese Medicine, Guangzhou University of Chinese Medicine, Dongguan, People's Republic of China.
Guangzhou University of Chinese Medicine · CNJinan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Edible bird's nest (EBN) is regarded as an immune-enhancing food in the People's Republic of China. The aim of this study is to demonstrate the efficiency of EBN in improving the immunity of mouse both in vivo and in vitro. We observed the effects of EBN on spleen lymphocytes proliferation and activation, as well as immunoglobulin isotypes as indicators. In addition, we evaluated the content of total sIgA in the intestinal juice to assess mucosal immunity. The results showed that EBN could promote the proliferation and activation of B-cells and increase IgE, IgA, IgM, and IgG3 levels. We also found that EBN extract can promote the secretion of sIgA in the small intestine. Using cyclophosphamide (CY), we established an immunosuppressed mouse model in which we identified a reversal influence on the ratio of CD3(+)/CD19(+) cells, which indicates that EBN also protects B-cells from the damage induced by CY. We also applied polymyxin B to exclude the interference of lipopolysaccharide throughout the experiment. In conclusion, we found that EBN can reduce the intestinal immune injury induced by CY by accelerating the proliferation and activation of B-cells and enhancing antibody secretion of B-cells.

Indexed as

AnimalsAntibodiesBirdsB-LymphocytesCell ProliferationCyclophosphamideFemaleImmunity, MucosalImmunoglobulin A, SecretoryImmunosuppressive AgentsMateria MedicaMedicine, Chinese TraditionalMiceMice, Inbred BALB CSpleenAntibodiesCyclophosphamideImmunoglobulin A, SecretoryImmunosuppressive AgentsMateria MedicachemotherapyEBNimmunological enhancementintestinal mucosal immune

Identifiers

PMID26855562
PMCPMC4727516
OpenAlexW2290277256

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.